Despite being members of gut microbiota, Enterobacteriaceae are associated with many severe infections such as bloodstream infections. The β-lactam drugs have been the cornerstone of antibiotic therapy for such infections. However, the overuse of these antibiotics has contributed to select β-lactam-resistant Enterobacteriaceae isolates, so that β-lactam resistance is nowadays a major concern worldwide. The production of enzymes that inactivate β-lactams, mainly extended-spectrum β-lactamases and carbapenemases, can confer multidrug resistance patterns that seriously compromise therapeutic options. Further, β-lactam resistance may result in increases in the drug toxicity, mortality, and healthcare costs associated with Enterobacteriaceae infections. Here, we summarize the updated evidence about the molecular mechanisms and epidemiology of β-lactamase-mediated β-lactam resistance in Enterobacteriaceae, and their potential impact on clinical outcomes of β-lactam-resistant Enterobacteriaceae infections.

De Angelis, G., Giacomo, P. D., Posteraro, B., Sanguinetti, M., Tumbarello, M., Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, 2020; 21 (14): 1-22. [doi:10.3390/ijms21145090] [http://hdl.handle.net/10807/166937]

Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae

De Angelis, Giulia;Posteraro, Brunella;Sanguinetti, Maurizio;Tumbarello, Mario
2020

Abstract

Despite being members of gut microbiota, Enterobacteriaceae are associated with many severe infections such as bloodstream infections. The β-lactam drugs have been the cornerstone of antibiotic therapy for such infections. However, the overuse of these antibiotics has contributed to select β-lactam-resistant Enterobacteriaceae isolates, so that β-lactam resistance is nowadays a major concern worldwide. The production of enzymes that inactivate β-lactams, mainly extended-spectrum β-lactamases and carbapenemases, can confer multidrug resistance patterns that seriously compromise therapeutic options. Further, β-lactam resistance may result in increases in the drug toxicity, mortality, and healthcare costs associated with Enterobacteriaceae infections. Here, we summarize the updated evidence about the molecular mechanisms and epidemiology of β-lactamase-mediated β-lactam resistance in Enterobacteriaceae, and their potential impact on clinical outcomes of β-lactam-resistant Enterobacteriaceae infections.
2020
Inglese
De Angelis, G., Giacomo, P. D., Posteraro, B., Sanguinetti, M., Tumbarello, M., Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, 2020; 21 (14): 1-22. [doi:10.3390/ijms21145090] [http://hdl.handle.net/10807/166937]
File in questo prodotto:
File Dimensione Formato  
article Molecular Mechanisms Epidemiology and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.33 MB
Formato Adobe PDF
1.33 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/166937
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 63
social impact